by admin | Sep 28, 2021 | News
Award-winning healthcare IT PR agency and innovative healthcare data quality platform provider partner to amplify client’s thought leadership, technology offerings
SCOTTSDALE, Ariz., Sept. 28, 2021 – Amendola Communications, a nationally recognized, award-winning healthcare and technology public relations and marketing firm, announced that it is re-engaging with former client 4medica®, a leader in healthcare data quality and patient matching technology, to amplify client successes and thought leadership.
4medica had previously engaged Amendola as its agency of record and is now back for its third engagement. 4medica provides real-time clinical data management and healthcare interoperability software and services that offer clinicians and patients a unified view of clinical information across disparate care locations. 4medica’s mission can be summed up in its corporate tagline: “One Patient…One Record.”
“Our previous successful experience working with Amendola made re-engagement an easy decision,” said Gregg Church, president of 4medica. “The Amendola team thoroughly understands 4medica’s technology and business model and how it benefits patients, provider organizations, laboratories, health information exchanges and health plans. They are the ideal partner to communicate the value we offer to our target audience and healthcare media.”
Amendola is implementing a comprehensive media and communications plan for 4medica that will showcasethe company’s thought leadership, current technology and services, new offerings, accomplishments, customer wins, and industry partnerships.
“4medica has a long commitment to improving data quality for clinicians, patients, health information exchanges and health plans,” said agency CEO Jodi Amendola. “And, now more than ever there is a crucial need for quality data in healthcare. We are excited to once again be working with Dr. Bess, Gregg and their team on public relations and marketing initiatives to get the word out about 4medica’s healthcare data quality solutions.”
4medica is based in Marina del Rey, Calif.
About Amendola Communications
Amendola is an award-winning, insights-driven public relations and marketing firm that integrates media relations, social media, content and lead gen programs to move healthcare, life sciences/pharma and healthcare IT decision-makers to action. The agency represents some of the industry’s best-known brands as well as groundbreaking startups that are disrupting the status quo. Nearly 90% of its client base represents multi-year clients and/or repeat client executives. Amendola’s seasoned team of PR and marketing pros understand the ongoing complexities of the healthcare ecosystem and provide strategic guidance and creative direction to drive positive ROI, boost reputation and increase market share. Making an impact since 2003, Amendola combines traditional and digital media to fuel meaningful and measurable growth. For more information about the industry’s “A-Team,” visit www.acmarketingpr.com, and follow us on Twitter and LinkedIn.
About 4medica
For more than two decades, 4medica® solves data integrity, financial and wellness management challenges to achieve true clinical interoperability and transparency. 4medica’s Perfect Order for Perfect Payment™ integrates end-to-end high-volume revenue cycle management services. Our Big Data Management and Clinical Data Exchange cloud solutions facilitate patient identity management and data exchange to ensure the right data is captured at the right time, the first time, guaranteeing an unprecedented 1% patient record duplication rate. 4medica has processed up to 6 billion clinical results representing more than 70 million patient identities. The company connects 40,000-plus physicians to hundreds of ACOs, HIEs, HINs, hospitals, health systems, laboratories, radiology imaging centers and payers nationwide.
Media Contact: Marcia Rhodes, Amendola Communications, mrhodes@acmarketingpr.com
by admin | Aug 17, 2021 | News
Award-winning healthcare IT PR agency and fast-growing decentralized clinical trial (DCT) technology company align to advance the future of global healthcare research
SCOTTSDALE, Ariz., August 17, 2021 – Amendola Communications, a nationally recognized, award-winning healthcare and technology public relations and marketing firm, announced today that Curebase, a company committed to democratizing access to clinical studies, has selected the agency to launch a comprehensive media and communications program highlighting its innovative Decentralized Clinical Trial (DCT) software platform and work to make clinical trials not only more patient-centric but also faster and more cost-effective. The decision comes after an extensive review of other national agencies.
Curebase is engineering a new approach to the entire clinical trial process with a unique DCT model that revolves around the patient’s lifestyle, enabling diverse studies with broader patient populations. The Curebase platform allows sponsors, CROs and physicians to conduct first-of-their kind study designs in which patients participate both at home and in real-world settings with best-in-class software experiences.
“We are excited to leverage Amendola, which brings a stealthy team, strategic healthcare IT expertise, and a long history of proven wins,” said Tom Lemberg, founder and CEO of Curebase. “We are proud to have helped many companies rapidly complete their clinical research, including those who achieved emergency use authorization during the pandemic. Our vision is to make clinical research an option for all patients, regardless of their care setting, and we are certain the Amendola team will be terrific partners in these efforts.”
“We look forward to the opportunity to help bring Curebase’s vision for a democratized clinical research industry to life,” said agency CEO Jodi Amendola. “They are a fast-rising powerhouse in the DCT space—developing innovative approaches for their clients and redefining how the world executes healthcare research. Curebase is building a future that includes better diversity, quicker enrollment, and improved patient satisfaction for all clinical trials.”
To learn more about Amendola, visit www.acmarketingpr.com. To learn more about Curebase, visit www.curebase.com.
About Amendola
Amendola is an award-winning, insights-driven public relations and marketing firm that integrates media relations, social media, content and lead gen programs to move healthcare, life sciences/pharma and healthcare IT decision-makers to action. The agency represents some of the industry’s best-known brands as well as groundbreaking startups that are disrupting the status quo. Nearly 90% of its client base represents multi-year clients and/or repeat client executives. Amendola’s seasoned team of PR and marketing pros understand the ongoing complexities of the healthcare ecosystem and provide strategic guidance and creative direction to drive positive ROI, boost reputation and increase market share. Making an impact since 2003, Amendola combines traditional and digital media to fuel meaningful and measurable growth. For more information about the industry’s “A-Team,” visit www.acmarketingpr.com, and follow us on Twitter and LinkedIn.
About Curebase
At Curebase, our mission is to bring quality medical innovations to patients faster and improve human wellbeing through more efficient clinical studies. We are proving that clinical research can be radically accelerated if we empower physicians everywhere to enroll patients in the communities where they live. By applying cutting edge clinical software and remote study management techniques to the problem, we are reinventing clinical trials and research from the ground up. For more information, please visit www.curebase.com.
Media Contact: Marcia Rhodes, mrhodes@acmarketingpr.com
by Brandon Glenn | May 26, 2021 | Blog
As artificial intelligence (AI) continues its inexorable march towards consuming more and more jobs previously done by humans, it may be a question of when, rather than if, humans become the new horses.
Think, for a minute, about how absolutely essential horses were to the economy 200 years ago. With much of the economy still industrializing and dependent on agriculture, horses were vital to the farm work that produced the world’s food. With no automobiles, horses also played a critical role in transportation, delivering goods to market and enabling humans to travel in coaches or by horseback.
Horses were so important that the U.S. equine population grew six-fold between 1840 and 1900 to more than 21 million horses and mules, according to a report in Foreign Affairs. Then came the internal combustion engine, replacing horses with cars in cities and tractors on farms. The U.S. equine population plummeted to 3 million by 1960, a drop of 88% in just 60 years.
For decades if not centuries, a related debate has loomed, ranging from “The Grapes of Wrath” to “2001: A Space Odyssey” and many others: Will technology replace and make human labor irrelevant? (Given that McKinsey reported five years ago that “currently demonstrated technologies could automate 45% of the activities people are paid to perform,” this is a subject that should be a concern for all workers – and that was five years ago!)
Now, with the rise of AI in marketing and public relations, the “Are humans the new horses?” question has begun to hit a little closer to home for PR professionals. Today, we may use AI software for routine, manual, time-consuming tasks such as transcribing interviews. Tomorrow – as AI gets better and smarter, which it most certainly will – we may use AI to write press releases, product descriptions, website copy and the like.
Once AI gets good enough to do that, it will likely begin to take human jobs. Sure, companies will still need some humans to feed information into the AI software to help the software write a press release, but assistance from AI will mean that companies need far fewer humans to produce the same amount of output.
Already, we’re seeing some examples of PR and marketing AI software – just not the kind that is sophisticated enough to take human jobs in a significant way. Copy.ai promises an “end to writer’s block” by helping users “generate marketing copy in seconds.” (I signed up for a seven-day trial and played around the software a little bit to write a product description; it seemed pretty good.) Similarly, Contilt pledges to “put the power of AI at your fingertips” by using software to generate article drafts and do research. No doubt there are plenty of similar startups today, and there will plenty more in the future.
These companies like to sell their AI as tools that will help humans do their jobs, better, which is true enough in the beginning. Then the AI gets smarter, and it begins to approach, but not meet, humans’ ability to edit content or draft a byline, for example. At this point, we’ve started on the slippery slope to where AI’s “good enough” work product becomes so much cheaper for companies to produce than a human-written article, that “good enough” becomes the industry standard for all articles and human writers start to lose their jobs. What a time to be alive!
So what’s a concerned PR professional to do? Data scientist Michael McBride offers three points of advice:
- Don’t get cocky: In one notable survey, 90% of responders thought that up to half of jobs would be lost to automation within five years, but 91% didn’t think there was any risk to their job. Don’t fall into the “It can’t happen to me” trap. It can.
- Make a process map of your job (extreme kudos to anyone who actually does this!): Create a process map that “visualizes the set of decisions and actions that make up your day-to-day life.”
- Double down on soft skills: Professions that require a tremendous amount of empathy and human interaction are among those least likely to be automated.
The good news is that, as it stands in 2021, there are still PR jobs available. Humans haven’t become horses – yet. Nonetheless, prepare for the coming onslaught of AI as if your career depends on it, because it probably does.
by admin | Apr 13, 2021 | News
Award-winning Health and Health tech PR and marketing agency and innovative pharmacy solutions provider partner to amplify client successes and industry best practices
SCOTTSDALE, Ariz., April 13, 2021 – Amendola Communications, a nationally recognized, award-winning healthcare, health tech and life sciences public relations and marketing firm, announced today that FDS Amplicare has selected the firm as its public agency of record. Amendola is implementing a comprehensive media and communications program that will showcasethe success of FDS Amplicare’s collaborative work with clients and bring greater awareness of its pharmacy software solutions, which include business intelligence, medication synchronization, claims reconciliation and medical billing.
“We are strong advocates for community pharmacists, who have so many stories to share, explains David Roth, chief growth officer, FDS Amplicare. “It has been a challenge to break through the COVID news cycle, but Amendola’s broad experience and deep relationships with pharmacy and healthcare media and digital influencers is what got our attention and they have delivered since day one. They generated immediate visibility with creative storytelling in our top tier media targets and we look forward to ongoing awareness and market momentum.”
FDS Amplicare has more than 30 years of experience in delivering pharmacy software solutions ranging from claims reconciliation and medical billing to business intelligence, patient communications, and Medicare plan selection. By combining proven technologies and pharmacy clinical and financial expertise, these solutions help pharmacies and their patients save time and money while delivering quality patient care.
Welcoming FDS Amplicare’s industry-leading pharmacy software solutions to the agency roster, Jodi Amendola, CEO of Amendola said, “We value FDS’ commitment to advancing financial and operational efficiencies of community-based pharmacies. It aligns perfectly with our results-oriented approach and passion for improving the healthcare system. It has been a pleasure to leverage their unique data, client successes and vision to the fast-changing market.”
To learn more about Amendola, visit www.acmarketingpr.com. To learn more about FDS Amplicare, visit www.fdsrx.com or www.Amplicare.com.
About Amendola Communications
Amendola is an award-winning, insights-driven public relations and marketing firm that integrates media relations, social media, content and lead gen programs to move healthcare, life sciences/pharma and healthcare IT decision-makers to action. The agency represents some of the industry’s best-known brands as well as groundbreaking startups that are disrupting the status quo. Nearly 90% of its client base represents multi-year clients and/or repeat client executives. Amendola’s seasoned team of PR and marketing pros understand the ongoing complexities of the healthcare ecosystem and provide strategic guidance and creative direction to drive positive ROI, boost reputation and increase market share. Making an impact since 2003, Amendola combines traditional and digital media to fuel meaningful and measurable growth. For more information about the industry’s “A-Team,” visit www.acmarketingpr.com, and follow us on Twitter and LinkedIn.
About FDS Amplicare
FDS Amplicare strengthens the health of pharmacies and their patients. Through the delivery of innovative software products and services, we enable the evolution of the clinically focused New Era Pharmacy, empowering our clients to provide comprehensive pharmacy and clinical care services for their communities. To learn more about FDS Amplicare, visit www.fdsrx.com or www.Amplicare.com.
by admin | Jan 28, 2021 | News
Healthcare IT PR agency aims to amplify voice of enterprise-ready virtual healthcare platform through media engagement
SCOTTSDALE, Ariz., Jan. 28, 2021 – Amendola Communications, a nationally recognized, award-winning healthcare and technology public relations and marketing firm, announces that virtual care leader eVisit has selected the group to manage its media outreach and thought leadership initiatives. The decision comes after an extensive review of other national agencies.
Founded in 2014, eVisit started with the goal to simplify the way healthcare organizations deliver care to their patients, regardless of where they are. As a result of the COVID-19 pandemic, telehealth has accelerated and virtual care solutions are a crucial way health systems and hospitals are delivering patient care and staying competitive. As a market leader, eVisit aims to ensure virtual visits are as easy as possible for providers and their patients, all while enhancing care quality.
“We are tremendously excited for this partnership with the Amendola team,” says Bret Larsen, CEO and Co-founder, eVisit. “We chose Amendola because of the team’s energy and passion for earned media, their keen ability to see a good story and their expertise in healthcare. As we continue toward our vision to simplify healthcare delivery to everyone, everywhere, we welcome their contribution with more eyes on our mission, technology and services, as well as to help us amplify eVisit’s unique position in the marketplace.”
Amendola joined forces with eVisit shortly after the virtual care leader raised $14 million in series A funding. In 2020, eVisit also saw their inclusion in the 2020 Gartner Market Guide for Virtual Care Solutions, which names eVisit as a Representative Vendor and cites the five critical capabilities to look for when selecting a virtual care solution. A tremendously useful tool for healthcare leaders, a complimentary copy of the Oct. 2020 Gartner Market Guide for Virtual Care Solutions can be accessed by clicking here.
Amendola will leverage its media relationships to help showcase eVisit’s services, innovation, consultative approach and customer successes, with an emphasis on securing exposure opportunities through media, speaking and other engagements for company leadership, its customers, and the providers and patients who benefit directly from the eVisit solution.
“Amendola thrives by telling stories. We earn media engagements by focusing on education, and by digging deep to find interesting angles that writers and reporters will want to delve into,” says agency CEO, Jodi Amendola. “As virtual care becomes the norm, it’s an honor to work with eVisit, a company whose founders are mission-driven and believe in the need to simplify healthcare delivery to everyone, everywhere.”
About Amendola
Amendola is an award-winning, insights-driven public relations and marketing firm that integrates media relations, social media, content and lead-gen programs to move healthcare, life sciences/pharma and healthcare IT decision-makers to action. The agency represents some of the industry’s best-known brands, as well as groundbreaking startups that are disrupting the status quo. Nearly 90% of its client base represents multi-year clients and/or repeat client executives. Amendola’s seasoned team of PR and marketing pros understand the ongoing complexities of the healthcare ecosystem and provide strategic guidance and creative direction to drive positive ROI, boost reputation and increase market share. Making an impact since 2003, Amendola combines traditional and digital media to fuel meaningful and measurable growth. For more information about the industry’s “A-Team,” visit www.acmarketingpr.com, and follow us on Twitter and LinkedIn.
About eVisit
eVisit simplifies healthcare delivery with its market-leading virtual care platform. With eVisit, healthcare organizations can deliver faster, more accessible virtual care using their own network of providers, regardless of specialty. eVisit works seamlessly across enterprise service lines and departments to improve outcomes, reduce costs, and boost revenue. Based in Mesa, Ariz., eVisit helps more than 100 healthcare organizations, including the largest systems in the U.S., innovate and succeed in today’s changing healthcare market. eVisit is a Representative Vendor in the Gartner 2020 Market Guide for Virtual Care. Get your complimentary copy here. For more information, visit evisit.com.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
